Results
|
|
941.
|
|
|
|
942.
|
Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene. [electronic resource] by
- Rizvi, Naiyer A
- Rusch, Valerie
- Pao, William
- Chaft, Jamie E
- Ladanyi, Marc
- Miller, Vincent A
- Krug, Lee M
- Azzoli, Christopher G
- Bains, Manjit
- Downey, Robert
- Flores, Raja
- Park, Bernard
- Singh, Bhuvanesh
- Zakowski, Maureen
- Heelan, Robert T
- Shen, Ronglai
- Kris, Mark G
Producer: 20111007
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
|
943.
|
|
|
|
944.
|
|
|
|
945.
|
|
|
|
946.
|
|
|
|
947.
|
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial. [electronic resource] by
- Wu, Yi-Long
- Cheng, Ying
- Zhou, Xiangdong
- Lee, Ki Hyeong
- Nakagawa, Kazuhiko
- Niho, Seiji
- Tsuji, Fumito
- Linke, Rolf
- Rosell, Rafael
- Corral, Jesus
- Migliorino, Maria Rita
- Pluzanski, Adam
- Sbar, Eric I
- Wang, Tao
- White, Jane Liang
- Nadanaciva, Sashi
- Sandin, Rickard
- Mok, Tony S
Producer: 20171215
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
|
948.
|
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. [electronic resource] by
- Mok, Tony S K
- Wu, Yi-Long
- Kudaba, Iveta
- Kowalski, Dariusz M
- Cho, Byoung Chul
- Turna, Hande Z
- Castro, Gilberto
- Srimuninnimit, Vichien
- Laktionov, Konstantin K
- Bondarenko, Igor
- Kubota, Kaoru
- Lubiniecki, Gregory M
- Zhang, Jin
- Kush, Debra
- Lopes, Gilberto
Producer: 20190522
In:
Lancet (London, England) vol. 393
Availability: No items available.
|
|
|
949.
|
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. [electronic resource] by
- Baron, Andre T
- Cora, Elsa M
- Lafky, Jacqueline M
- Boardman, Cecelia H
- Buenafe, Marites C
- Rademaker, Alfred
- Liu, Dachao
- Fishman, David A
- Podratz, Karl C
- Maihle, Nita J
Producer: 20030530
In:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 12
Availability: No items available.
|
|
|
950.
|
|
|
|
951.
|
All-trans retinoic acid attenuates ultraviolet radiation-induced down-regulation of aquaporin-3 and water permeability in human keratinocytes. [electronic resource] by
- Cao, Cong
- Wan, Shu
- Jiang, Qin
- Amaral, Ashley
- Lu, Shan
- Hu, Gang
- Bi, Zhigang
- Kouttab, Nicola
- Chu, Wenming
- Wan, Yinsheng
Producer: 20080325
In:
Journal of cellular physiology vol. 215
Availability: No items available.
|
|
|
952.
|
|
|
|
953.
|
Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer. [electronic resource] by
- Sasaki, Hidefumi
- Endo, Katsuhiko
- Okuda, Katsuhiro
- Kawano, Osamu
- Kitahara, Naoto
- Tanaka, Hisaichi
- Matsumura, Akihide
- Iuchi, Keiji
- Takada, Minoru
- Kawahara, Masaaki
- Kawaguchi, Tomoya
- Yukiue, Haruhiro
- Yokoyama, Tomoki
- Yano, Motoki
- Fujii, Yoshitaka
Producer: 20080624
In:
Journal of cancer research and clinical oncology vol. 134
Availability: No items available.
|
|
|
954.
|
|
|
|
955.
|
|
|
|
956.
|
Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification. [electronic resource] by
- Furugaki, Koh
- Fukumura, Junko
- Iwai, Toshiki
- Yorozu, Keigo
- Kurasawa, Mitsue
- Yanagisawa, Mieko
- Moriya, Yoichiro
- Yamamoto, Kaname
- Suda, Kenichi
- Mizuuchi, Hiroshi
- Mitsudomi, Tetsuya
- Harada, Naoki
Producer: 20160531
In:
International journal of cancer vol. 138
Availability: No items available.
|
|
|
957.
|
|
|
|
958.
|
|
|
|
959.
|
EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients. [electronic resource] by
- Li, Yu-Hong
- Wang, Fang
- Shen, Lin
- Deng, Yan-Ming
- Shao, Qiong
- Feng, Fen
- An, Xin
- Wang, Feng-Hua
- Wang, Zhi-Qiang
- Xu, Rui-Hua
- Shao, Jian-Yong
Producer: 20110628
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
|
960.
|
|